Last price paid | 1.13 | |
Change | +1.80% [ +0.02 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 12.06.2024 17:20 |
Fixing | n.a. |
Settlement date | 21.02.2024 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +123.00% |
Year to date (YTD) | n.a. |
1 month | +82.26% |
3 months | +37.80% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.50 |
Underlying price on issue | 857.40 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1305137841 |
Symbol | INOOQZ |
Security | 130513784 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Novo Nordisk -B-, DK0062498333 |
Underlying ISIN | DK0062498333 |
Funding level | 775.317800 |
Stop-loss level | 804.660200 |
Distance to stop-loss level | 18.48% |
Long/Short type | Long |
Subscription ratio | 25.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 19.02.2024 |
Premium | 0.34% |
Premium p.a. | n.a. |
Leverage | 4.58 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 211.782200 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Alcon AG | 82.70 |
ROCHE GS | 245.00 |
SWISSCOM N | 494.60 |
KUEHNE & NAGEL | 260.60 |
ZURICH INSURANCE | 474.60 |